# COEPTIS THERAPEUTICS HLDGS I (COEPW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/COEPW/

- Reporting holders: 3
- Reported value: $2.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [RIVERNORTH CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1447578-rivernorth-capital-management-llc/) | $1.5K | 147,970 | 0.0% | 15 |
| [Meteora Capital, LLC](https://holderbook.com/funds/1905106-meteora-capital-llc/) | $1.2K | 114,873 | 0.0% | 2 |
| [SkyView Investment Advisors, LLC](https://holderbook.com/funds/1848237-skyview-investment-advisors-llc/) | $0 | 50,122 | 0.0% | 16 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 3 | $2.7K |
| Q1 2026 | 10 | $6.3K |
| Q4 2025 | 10 | $4.6K |
| Q3 2025 | 11 | $14.9K |
| Q2 2025 | 13 | $25.1K |
| Q1 2025 | 13 | $9.7K |
| Q4 2024 | 13 | $21.4K |
| Q3 2024 | 17 | $27.4K |
| Q2 2024 | 17 | $61.3K |
| Q1 2024 | 19 | $63.8K |
| Q4 2023 | 18 | $61.5K |
| Q3 2023 | 18 | $47.0K |

